Article

Keys to the glaucoma code: Early assessment, diagnosis, and treatment

Perhaps more valuable if less provocative than clues to the "Da Vinci Code," as set out in the bestselling thriller, are the keys to the glaucoma code, which could lead to improvements in assessment, diagnosis, and treatment.

New Orleans-Perhaps more valuable if less provocative than clues to the "Da Vinci Code," as set out in the bestselling thriller, are the keys to the glaucoma code, which could lead to improvements in assessment, diagnosis, and treatment.

Speakers at a Sunday evening CME session held at the Audubon Aquarium of the Americas addressed a range of crucial glaucoma issues, starting with a presentation on the glaucoma continuum by Robert N. Weinreb, MD, University of California, San Diego. Dr. Weinreb also served as program chairman and moderator.

Christopher A. Girkin, MD, MSPH, University of Alabama at Birmingham, spoke on the importance of early detection and diagnosis, while Davis S. Friedman, MD, MPH, explained global risk assessment and thresholds for treatment of ocular hypertension. Richard K. Parrish II, MD, University of Miami School of Medicine, described how comprehensive glaucoma therapy must move beyond IOPs.

The program was jointly sponsored by Ophthalmology Times and the New York Eye and Ear Infirmary and supported by an unrestricted educational grant from Pfizer Ophthalmics.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
© 2025 MJH Life Sciences

All rights reserved.